Alex holds a BSc in Pharmacy from Taipei Medical University and a MSc in Health Economics and Decision Modelling from the University of Sheffield in the School of Health and Related Research (ScHARR). He is a registered Pharmacist in Taiwan. During his MSc degree, he incorporated a Distributional Cost-Effectiveness into Sheffield Tobacco Policy Model to
Susi has a Masters in Economic Management and Policy from the University of Strathclyde and a Bachelors in Anatomy and Physiology from the University of Leeds. She has worked in the field of health economics, with a focus on modelling, for over 7 years both in academic roles at the University of Sheffield and the
Rene sets up and lead the European financial team and improve and standardize the financial end to end processes.
Lydia is a Senior Research Consultant with experience in evidence synthesis activities including targeted reviews to inform early value frameworks and systematic reviews to support HTA submissions. She also has experience in conducting feasibility assessments for quantitative analyses including network meta-analyses, surrogate endpoint analyses, and post-hoc analyses of clinical trial data. As a consultant, Lydia
Maria has a wealth of experience in global systematic literature reviews and strengthens the joint capabilities of Cytel and Ingress-Health in this field. As Senior Director HEOR, Maria leads projects from the United Kingdom.
